Sahajanand Medical Technologies opened higher at ₹505.00, compared with its previous close of ₹504.65. In the last trading session on 13 Nov 2026, the stock traded between ₹492.05 and ₹544.00, with an average traded price of ₹527.34. It showed an upward intraday trend.
An investment of ₹10,000 made 1 year ago in Sahajanand Medical Technologies is now worth
₹ 15,522.00
Giving a profit of
₹ 5,522.00 (55.22%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+29.30 (+5.81%)
Day High
₹544.00
Day Low
₹492.05
Day Open
₹505.00
Prev Close
₹504.65
Volume
19,27,485
Value Traded
₹101.64 Cr
1W Return
9.47%
1M Return
55.22%
3M Return
55.22%
6M Return
55.22%
1Y Return
55.22%
Market Cap (₹ Cr.)
5,427
PE Ratio
74.10
PB Ratio
7.36
Dividend Yield
-
ROE
9.84%
ROCE
13.30%
Book Value (₹)
68.45
Face Value (₹)
1.00
EPS (TTM)
2.63
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
9.47%
6 Weeks
-
1 Month
55.22%
3 Months
55.22%
9 Months
55.22%
Sahajanand Medical Technologies to host investor meet on Nov 16
Sahajanand Medical Technologies scheduled a virtual investor meeting for November 16, 2026. The meeting involves a one-on-one session with AIF Accurate Advisor. Disclosure complies with SEBI (LODR) Regulations, 2015. Schedule remains subject to change based on investor or company exigencies.
3 days agoSahajanand Medical Q2FY27 net profit rises 26.5% YoY; releases call recording
Net profit rose 26.5% YoY to ₹2,646.92 lakh in Q2FY27. Revenue from operations increased 24.7% YoY to ₹37,341.01 lakh. Audio recording of Q2FY27 earnings call released on November 6, 2026. Subsidiary to invest up to $780,000 in US-based SNP Medical Corp.
8 days agoSahajanand Medical appoints Amit Jaste & Associates as secretarial auditor
Sahajanand Medical Technologies appointed M/s Amit Jaste & Associates as secretarial auditor. Appointment covers five financial years from FY26-27 to FY30-31. Decision subject to approval by shareholders. Firm led by Mr. Amit Jaste with over 22 years of experience.
8 days agoSahajanand Medical receives GST recovery notice of ₹34.30 lakh
Received GST recovery notice of ₹34.30 lakh from Jharkhand State Tax authorities. Demand relates to ITC eligibility disputes for FY19 through FY21. Company states no material financial or operational impact currently. Matter previously litigated before Appellate Authorities regarding demand and penalty.
9 days agoInvesco Mutual Fund raises Sahajanand Medical stake to 5.05%
Invesco Mutual Fund increased its stake in Sahajanand Medical Technologies to 5.05%. Acquired 44,20,453 shares via open market transactions on October 23, 2026. Aggregate holding rose from 0.71% to 5.05%, crossing the substantial acquisition threshold.
18 days agoSahajanand Medical Technologies receives DGGI summons over GST inquiry
Sahajanand Medical Technologies received a summons from DGGI Mumbai on October 23, 2026. Inquiry relates to GST compliance on re-imbursements to foreign subsidiaries for clinical trials. Company states no material financial impact and confirms full cooperation with authorities.
21 days ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,493.20 | +7.11% | ₹17,207.64 | 113.50 | +85.03% | |
| ₹1,681.20 | -0.70% | ₹17,040.89 | 54.30 | -16.99% | |
| ₹315.45 | +1.24% | ₹1,678.39 | 222.90 | +21.84% | |
| ₹488.30 | -11.84% | ₹1,139.12 | 23.20 | +42.36% | |
| ₹204.00 | -1.24% | ₹1,122.60 | 35.10 | -36.52% | |
| ₹472.95 | +3.26% | ₹827.36 | 67.70 | -17.53% | |
| ₹384.35 | -0.88% | ₹683.94 | 23.60 | -39.71% | |
| ₹138.36 | -2.54% | ₹615.02 | 17.70 | -39.61% | |
| ₹173.90 | +0.34% | ₹336.28 | 26.60 | +83.34% | |
| ₹306.55 | +1.29% | ₹292.51 | 61.10 | +12.37% | |
| ₹136.80 | +2.55% | ₹260.47 | 49.60 | -51.64% | |
| ₹141.00 | -4.08% | ₹148.24 | 17.20 | -47.99% |
An investment of ₹10,000 made 1 year ago in Sahajanand Medical Technologies is now worth
₹ 15,522.00
Giving a profit of
₹ 5,522.00 (55.22%)
Note: Past profits do not guarantee future returns.